JP2002513026A5 - - Google Patents

Download PDF

Info

Publication number
JP2002513026A5
JP2002513026A5 JP2000545867A JP2000545867A JP2002513026A5 JP 2002513026 A5 JP2002513026 A5 JP 2002513026A5 JP 2000545867 A JP2000545867 A JP 2000545867A JP 2000545867 A JP2000545867 A JP 2000545867A JP 2002513026 A5 JP2002513026 A5 JP 2002513026A5
Authority
JP
Japan
Prior art keywords
carbon atoms
alkylene
hal
cycloalkyl
conha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000545867A
Other languages
English (en)
Japanese (ja)
Other versions
JP4242561B2 (ja
JP2002513026A (ja
Filing date
Publication date
Priority claimed from DE19819023A external-priority patent/DE19819023A1/de
Application filed filed Critical
Publication of JP2002513026A publication Critical patent/JP2002513026A/ja
Publication of JP2002513026A5 publication Critical patent/JP2002513026A5/ja
Application granted granted Critical
Publication of JP4242561B2 publication Critical patent/JP4242561B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000545867A 1998-04-29 1999-04-23 ホスホジエステラーゼv阻害作用を有する凝縮チエノピリミジン類 Expired - Fee Related JP4242561B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19819023.9 1998-04-29
DE19819023A DE19819023A1 (de) 1998-04-29 1998-04-29 Thienopyrimidine
PCT/EP1999/002738 WO1999055708A1 (de) 1998-04-29 1999-04-23 Kondensierte thienopyrimidine mit pde v inhibierender wirkung

Publications (3)

Publication Number Publication Date
JP2002513026A JP2002513026A (ja) 2002-05-08
JP2002513026A5 true JP2002513026A5 (enExample) 2006-06-22
JP4242561B2 JP4242561B2 (ja) 2009-03-25

Family

ID=7866082

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000545867A Expired - Fee Related JP4242561B2 (ja) 1998-04-29 1999-04-23 ホスホジエステラーゼv阻害作用を有する凝縮チエノピリミジン類

Country Status (26)

Country Link
US (1) US6495557B1 (enExample)
EP (1) EP1084125B1 (enExample)
JP (1) JP4242561B2 (enExample)
KR (1) KR20010042628A (enExample)
CN (1) CN1142936C (enExample)
AR (1) AR016233A1 (enExample)
AT (1) ATE314374T1 (enExample)
AU (1) AU743230B2 (enExample)
BR (1) BR9910032A (enExample)
CA (1) CA2328280C (enExample)
CO (1) CO5011050A1 (enExample)
CZ (1) CZ291109B6 (enExample)
DE (2) DE19819023A1 (enExample)
ES (1) ES2255754T3 (enExample)
HU (1) HUP0101832A3 (enExample)
ID (1) ID27049A (enExample)
MY (1) MY121864A (enExample)
NO (1) NO20005434L (enExample)
PL (1) PL343637A1 (enExample)
RU (1) RU2224760C2 (enExample)
SK (1) SK15972000A3 (enExample)
TR (1) TR200003144T2 (enExample)
TW (1) TWI232220B (enExample)
UA (1) UA66856C2 (enExample)
WO (1) WO1999055708A1 (enExample)
ZA (1) ZA200006994B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19928146A1 (de) 1999-06-19 2000-12-21 Merck Patent Gmbh Thienopyrimidine
DE19943815A1 (de) * 1999-09-14 2001-03-15 Merck Patent Gmbh Verwendung von Thienopyrimidinen
DE19944604A1 (de) * 1999-09-17 2001-03-22 Merck Patent Gmbh Aminderivate
AU2001228454A1 (en) * 2000-01-13 2001-07-24 Merck Patent G.M.B.H Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary
DE10001021A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische Zubereitung
DE10010612A1 (de) * 2000-03-03 2001-09-27 Merck Patent Gmbh Verwendung von PDE V-Inhibitoren
DE10017947A1 (de) * 2000-04-11 2001-10-25 Merck Patent Gmbh Verfahren zur Herstellung benzo-annelierter Heterocyclen
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
CZ20031722A3 (cs) * 2000-12-19 2003-09-17 Merck Patent Gmbh Farmaceutický prostředek obsahující deriváty thienopyrimidinu a antitrombotika, vápníkové antagonisty, prostaglandiny nebo deriváty prostaglandinu
DE10064994A1 (de) * 2000-12-23 2002-07-04 Merck Patent Gmbh Sulfamidothienopyrimidine
SK10762003A3 (sk) * 2001-01-31 2004-01-08 Merck Patent Gmbh Farmaceutický prostriedok obsahujúci parazolo-[4,3-d]pyrimidíny a nitráty alebo tienopyrimidíny a nitráty
DE10107261B4 (de) * 2001-02-16 2005-03-10 Merck Patent Gmbh Pharmazeutische Zusammensetzung
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
WO2003035653A1 (en) * 2001-10-26 2003-05-01 Nippon Soda Co.,Ltd. Pyridothienopyrimidine compound and salt thereof
EP1799653B1 (en) * 2004-08-20 2013-03-20 Bayer Intellectual Property GmbH Condensed thienopyrimidine derivatives for the treatment of cancer
ES2259891B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
ES2259892B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
EA016037B1 (ru) 2005-04-19 2012-01-30 Никомед Гмбх Рофлумиласт для лечения лёгочной гипертензии

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2657760B2 (ja) * 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
PH31122A (en) * 1993-03-31 1998-02-23 Eisai Co Ltd Nitrogen-containing fused-heterocycle compounds.
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
ATE163647T1 (de) 1993-08-26 1998-03-15 Ono Pharmaceutical Co 4-aminopyrimidin derivate
US5869486A (en) 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19632423A1 (de) 1996-08-12 1998-02-19 Merck Patent Gmbh Thienopyrimidine
DE19644228A1 (de) 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine

Similar Documents

Publication Publication Date Title
JP2002513026A5 (enExample)
JP2003531118A5 (enExample)
JP2002501057A5 (enExample)
JP2002541233A5 (enExample)
LU91417I2 (fr) "Maraviroc, optionnellement sous forme d'un sel pharmaceutiquement acceptable CELSENTRI"
JP2004516293A5 (enExample)
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
ATE270817T1 (de) Fungizide
JP2003508534A5 (enExample)
EP1153924A3 (en) Substituted 1,3-oxathiolanes with antiviral properties
JP2002539156A5 (enExample)
RU97114956A (ru) Способ ингибирования межклеточной адгезии и способ ингибирования воспалительного процесса
JP2004531479A5 (enExample)
AR028914A1 (es) 2-guanidino-4-aril-quinazolinas como inhibidores de nhe-3
JP2002510633A5 (enExample)
JP2004501940A5 (enExample)
NO951529D0 (no) 3-indolylpiperidiner
CA2379021A1 (en) New phenylpiperazines
EP0340754A3 (en) Monopersulfates of amino-(poly) percarboxylic acids
JP2000264961A5 (enExample)
JP2003506378A5 (enExample)
MY113518A (en) Benzothiazolone derivatives
JP2004516329A5 (enExample)
JP2002526530A5 (enExample)
JP2003508374A5 (enExample)